{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:51:40Z","timestamp":1792191100524,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s11904-005-0016-4","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T01:33:13Z","timestamp":1180056793000},"page":"194-199","source":"Crossref","is-referenced-by-count":191,"title":["The methamphetamine epidemic: Implications for HIV prevention and treatment"],"prefix":"10.1007","volume":"2","author":[{"given":"Grant","family":"Colfax","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0740-5472(03)00028-X","volume":"24","author":"M Cretzmeyer","year":"2003","unstructured":"Cretzmeyer M, Sarrazin MV, Huber DL, et al.: Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 2003, 24:267\u2013277.","journal-title":"J Subst Abuse Treat"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v21n01_02","volume":"21","author":"RA Rawson","year":"2002","unstructured":"Rawson RA, Anglin MD, Ling W: Will the methamphetamine problem go away? J Addict Dis 2002, 21:5\u201319.","journal-title":"J Addict Dis"},{"key":"16_CR3","volume-title":"Psychopharmacology: The Fourth Generation of Progress CD-ROM","author":"EH Ellinwood","year":"1998","unstructured":"Ellinwood EH, King G, Lee TH: Chronic amphetamine use and abuse. In Psychopharmacology: The Fourth Generation of Progress CD-ROM. Edited by Watson SJ. Philadelphia, PA: Lippincott, Williams & Wilkins; 1998."},{"key":"16_CR4","unstructured":"Suo S: Unnecessary epidemic. The Oregonian, October 3\u20137, 2004:1\u201324. Excellent overview of the methamphetamine epidemic."},{"key":"16_CR5","unstructured":"National Institute on Drug Abuse: InfoFacts: Nationwide trends: NIDA, http:\/\/www.drugabuse.gov\/Infofax\/nationtrends.html.2004."},{"key":"16_CR6","unstructured":"Methamphetamine treatment admission rates higher than those of cocaine and\/or heroin in western states. CESAR Fax 2005, 14:12."},{"key":"16_CR7","unstructured":"Substance Abuse and Mental Health Services Administration: 2003 National survey on drug use and health. http:\/\/oas.samhsa.gov\/NHSDA\/2k3NSDUH\/2k3results.htm."},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1300\/J069v21n01_03","volume":"21","author":"AK Cho","year":"2002","unstructured":"Cho AK, Melega WP: Patterns of methamphetamine abuse and their consequences. J Addict Dis 2002, 21:21\u201334.","journal-title":"J Addict Dis"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/aje\/kwh135","volume":"159","author":"G Colfax","year":"2004","unstructured":"Colfax G, Vittinghoff E, Husnik MJ, et al.: Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol 2004, 159:1002\u20131012.","journal-title":"Am J Epidemiol"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.1360-0443.2001.961115896.x","volume":"96","author":"R Stall","year":"2001","unstructured":"Stall R, Paul JP, Greenwood G, et al.: Alcohol use, drug use, and alcohol-related problems among men who have sex with men: the Urban Health Study. Addiction 2001, 96:1589\u20131601.","journal-title":"Addiction"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2105\/AJPH.93.11.1915","volume":"93","author":"H Thiede","year":"2003","unstructured":"Thiede H, Valleroy LA, MacKellar DA, et al.: Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health 2003, 93:1915\u20131921.","journal-title":"Am J Public Health"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00126334-200112010-00011","volume":"28","author":"GN Colfax","year":"2001","unstructured":"Colfax GN, Mansergh G, Guzman R, et al.: Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. J Acquir Immune Defic Syndr 2001, 28:373\u2013379.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"16_CR13","doi-asserted-by":"crossref","unstructured":"Mitchell SJ, Wong W, Kent CK, et al.: Methamphetamine use and sexual activity among HIV-infected patients in care\u2014San Francisco, 2004. Paper presented at National HIV Prevention Conference, Atlanta, GA; June 13\u201315, 2005.","DOI":"10.1089\/apc.2006.20.502"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0740-5472(02)00256-8","volume":"23","author":"RA Rawson","year":"2002","unstructured":"RawsonRA, Gonzales R, Brethen P: Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat 2002, 23:145\u2013150. An important review of treatment options.","journal-title":"J Subst Abuse Treat"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/appi.neuropsych.15.3.317","volume":"15","author":"TE Nordahl","year":"2003","unstructured":"NordahlTE, Salo R, Leamon M: Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003, 15:317\u2013325. An excellent review of the neurologic consequences of methamphetamine.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neubiorev.2003.11.003","volume":"27","author":"UD McCann","year":"2004","unstructured":"McCann UD, Ricaurte GA: Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci Biobehav Rev 2004, 27:821\u2013826.","journal-title":"Neurosci Biobehav Rev"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-2999(87)90616-9","volume":"135","author":"M Johnson","year":"1987","unstructured":"Johnson M, Stone DM, Hanson GR, et al.: Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 1987, 135:231\u2013234.","journal-title":"Eur J Pharmacol"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1523\/JNEUROSCI.3597-04.2004","volume":"24","author":"KA Mark","year":"2004","unstructured":"Mark KA, Soghomonian JJ, Yamamoto BK: High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci 2004, 24:11449\u201311456.","journal-title":"J Neurosci"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.158.8.1206","volume":"158","author":"Y Sekine","year":"2001","unstructured":"Sekine Y, Iyo M, Ouchi Y, et al.: Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001, 158:1206\u20131214.","journal-title":"Am J Psychiatry"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archpsyc.61.1.73","volume":"61","author":"ED London","year":"2004","unstructured":"London ED, Simon SL, Berman SM, et al.: Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004, 61:73\u201384.","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.158.3.383","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, et al.: Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry 2001, 158:383\u2013389.","journal-title":"Am J Psychiatry"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/10550490050148053","volume":"9","author":"SL Simon","year":"2000","unstructured":"Simon SL, Domier C, Carnell J, et al.: Cognitive impairment in individuals currently using methamphetamine. Am J Addict 2000, 9:222\u2013231.","journal-title":"Am J Addict"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0893-133X(00)00097-X","volume":"23","author":"TJ Ornstein","year":"2000","unstructured":"Ornstein TJ, Iddon JL, Baldacchino AM, et al.: Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000, 23:113\u2013126.","journal-title":"Neuropsychopharmacology"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"i100","DOI":"10.1093\/jurban\/jti029","volume":"82","author":"JA Peck","year":"2005","unstructured":"Peck JA, Reback CJ, Yang X, et al.: Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. J Urban Health 2005, 82:i100\u2013108.","journal-title":"J Urban Health"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpsyc.62.4.444","volume":"62","author":"TE Nordahl","year":"2005","unstructured":"Nordahl TE, Salo R, Natsuaki Y, et al.: Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2005, 62:444\u2013452.","journal-title":"Arch Gen Psychiatry"},{"key":"16_CR26","volume-title":"The Pharmacologic Basis of Therapeutics","year":"2001","unstructured":"Hardman JG, Limbird L, Gilman AG, eds.: The Pharmacologic Basis of Therapeutics. New York: McGrawHill, 2001."},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/429827","volume":"40","author":"NE Lee","year":"2005","unstructured":"Lee NE, Taylor MM, Bancroft E, et al.: Risk factors for community -associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005, 40:1529\u20131534.","journal-title":"Clin Infect Dis"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bdj.4812050","volume":"198","author":"C McGrath","year":"2005","unstructured":"McGrath C, Chan B: Oral health sensations associated with illicit drug abuse. Br Dent J 2005, 198:159\u2013162.","journal-title":"Br Dent J"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/02791072.2001.10399926","volume":"33","author":"JC Buffum","year":"2001","unstructured":"Buffum JC, Shulgin AT: Overdose of 2.3 grams of intravenous methamphetamine: case, analysis and patient perspective. J Psychoactive Drugs 2001, 33:409\u2013412.","journal-title":"J Psychoactive Drugs"},{"key":"16_CR30","first-page":"528","volume":"97","author":"KC Lan","year":"1998","unstructured":"Lan KC, Lin YF, Yu FC, et al.: Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc 1998, 97:528\u2013533.","journal-title":"J Formos Med Assoc"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0736-4679(99)00009-8","volume":"17","author":"JA Perez Jr","year":"1999","unstructured":"Perez JA, Jr, Arsura EL, Strategos S: Methamphetamine-related stroke: four cases. J Emerg Med 1999, 17:469\u2013471.","journal-title":"J Emerg Med"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.1991.03460090100040","volume":"265","author":"R Hong","year":"1991","unstructured":"Hong R, Matsuyama E, Nur K: Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 1991, 265:1152\u20131154.","journal-title":"JAMA"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/B:AIBE.0000017528.39338.75","volume":"8","author":"CJ Reback","year":"2004","unstructured":"Reback CJ, Larkins S, Shoptaw S: Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004, 8:87\u201398.","journal-title":"AIDS Behav"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0893-133X(97)00128-0","volume":"18","author":"W Ling","year":"1998","unstructured":"Ling W, Shoptaw S, Majewska D: Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 1998, 18:403\u2013404.","journal-title":"Neuropsychopharmacology"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0740-5472(02)00223-4","volume":"22","author":"SJ Semple","year":"2002","unstructured":"Semple SJ, Patterson TL, Grant I: Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat 2002, 22:149\u2013156.","journal-title":"J Subst Abuse Treat"},{"key":"16_CR36","unstructured":"Shoptaw S, Tross S, Stephens MA, et al.: A snapshot of HIV-related assessment and treatment services at participating clinical treatment providers in NIDA\u2019s clinical trials network. Paper presented at XIV International AIDS Conference. Barcelona, Spain; July 7\u201312, 2002."},{"key":"16_CR37","first-page":"93","volume":"168","author":"F Molitor","year":"1998","unstructured":"Molitor F, Truax SR, Ruiz JD,et al.: Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 1998, 168:93\u201397.","journal-title":"West J Med"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2105\/AJPH.91.6.953","volume":"91","author":"G Mansergh","year":"2001","unstructured":"Mansergh G, Colfax GN, Marks G, et al.: The Circuit Party Men\u2019s Health Survey: findings and implications for gay and bisexual men. Am J Public Health 2001, 91:953\u2013958.","journal-title":"Am J Public Health"},{"key":"16_CR39","first-page":"11","volume":"5","author":"JP Paul","year":"1993","unstructured":"Paul JP, Stall R, Davis F: Sexual risk for HIV transmission among gay\/bisexual men in substance-abuse treatment. AIDS Educ Prev 1993, 5:11\u201324.","journal-title":"AIDS Educ Prev"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1360-0443.1992.tb02694.x","volume":"87","author":"T Myers","year":"1992","unstructured":"Myers T, Rowe CJ, Tudiver FG, et al.: HIV, substance use and related behavior of gay and bisexual men: an examination of the Talking Sex project cohort. Br J Addict 1992, 87:207\u2013214.","journal-title":"Br J Addict"},{"key":"16_CR41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1360-0443.1994.tb03357.x","volume":"89","author":"JP Paul","year":"1994","unstructured":"Paul JP, Stall RD, Crosby GM, et al.: Correlates of sexual risk-taking among gay male substance abusers. Addiction 1994, 89:971\u2013983.","journal-title":"Addiction"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.olq.0000168280.34424.58","volume":"32","author":"W Wong","year":"2005","unstructured":"Wong W, Chaw JK, Kent CK, et al.: Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002\u20132003. Sex Transm Dis 2005, 32:458\u2013463.","journal-title":"Sex Transm Dis"},{"key":"16_CR43","doi-asserted-by":"crossref","unstructured":"Buchacz K, McFarland W, Kellog T, et al.: Amphetamine use is associated with increased HIV incidence among men who have sex with men (MSM) in San Francisco. AIDS 2005, In press.","DOI":"10.1097\/01.aids.0000180794.27896.fb"},{"key":"16_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v21n01_09","volume":"21","author":"RA Rawson","year":"2002","unstructured":"Rawson RA, Huber A, Brethen P, et al.: Status of methamphetamine users 2\u20135 years after outpatient treatment. J Addict Dis 2002, 21:107\u2013119.","journal-title":"J Addict Dis"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1081\/ADA-100101874","volume":"25","author":"F Molitor","year":"1999","unstructured":"Molitor F, Ruiz JD, Flynn N, et al.: Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999, 25:475\u2013493.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J082v41n02_02","volume":"41","author":"PN Halkitis","year":"2001","unstructured":"Halkitis PN, Parsons JT, Stirratt MJ: A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex 2001, 41:17\u201335.","journal-title":"J Homosex"},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00042560-199904150-00013","volume":"20","author":"E Stone","year":"1999","unstructured":"Stone E, Heagerty P, Vittinghoff E, et al.: Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic SyndrHum Retrovirol 1999, 20:495\u2013501.","journal-title":"J Acquir Immune Defic SyndrHum Retrovirol"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00126334-200211010-00013","volume":"31","author":"AR Wohl","year":"2002","unstructured":"Wohl AR, Johnson DF, Lu S, et al.: HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr 2002, 31:354\u2013360.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J013v40n03_03","volume":"40","author":"SJ Semple","year":"2004","unstructured":"Semple SJ, Grant I, Patterson TL: Female methamphetamine users: social characteristics and sexual risk behavior. Women Health 2004, 40:35\u201350.","journal-title":"Women Health"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.olq.0000148294.83012.d0","volume":"32","author":"LM Bogart","year":"2005","unstructured":"Bogart LM, Kral AH, Scott A, et al.: Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis 2005, 32:27\u201334.","journal-title":"Sex Transm Dis"},{"key":"16_CR51","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1086\/379894","volume":"188","author":"RJ Ellis","year":"2003","unstructured":"Ellis RJ, Childers ME, Cherner M, et al.: Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003, 188:1820\u20131826.","journal-title":"J Infect Dis"},{"key":"16_CR52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13550280290049660","volume":"8","author":"MA Gavrilin","year":"2002","unstructured":"Gavrilin MA, Mathes LE, Podell M: Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 2002, 8:240\u2013249.","journal-title":"J Neurovirol"},{"key":"16_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","volume":"10","author":"JD Rippeth","year":"2004","unstructured":"Rippeth JD, Heaton RK, Carey CL, et al.: Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004, 10:1\u201314.","journal-title":"J Int Neuropsychol Soc"},{"key":"16_CR54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00126334-200312150-00004","volume":"34","author":"D Langford","year":"2003","unstructured":"Langford D, Adame A, Grigorian A, et al.: Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 2003, 34:467\u2013474.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"16_CR55","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/381975","volume":"38","author":"A Urbina","year":"2004","unstructured":"Urbina A, Jones K: Crystal methamphetamine, its analogues, and HIV-infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 2004, 38:890\u2013894.","journal-title":"Clin Infect Dis"},{"key":"16_CR56","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(05)79824-X","volume":"352","author":"JA Henry","year":"1998","unstructured":"Henry JA, Hill IR: Fatal interaction between ritonavir and MDMA. Lancet 1998, 352:1751\u20131752.","journal-title":"Lancet"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/135965350000500108","volume":"5","author":"G Hales","year":"2000","unstructured":"Hales G, Roth N, Smith D: Possible fatal interaction between protease inhibitors and methamphetamine. Antivir Ther 2000, 5:19.","journal-title":"Antivir Ther"},{"key":"16_CR58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/09540120310001618621","volume":"15","author":"CJ Reback","year":"2003","unstructured":"Reback CJ, Larkins S, Shoptaw S: Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003, 15:775\u2013785.","journal-title":"AIDS Care"},{"key":"16_CR59","first-page":"5","volume":"18","author":"M Gorman","year":"2003","unstructured":"Gorman M, Halkitis P: Methamphetamine and club drug use and HIV. Focus 2003, 18:5\u20136.","journal-title":"Focus"},{"key":"16_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v21n01_01","volume":"21","author":"RA Rawson","year":"2002","unstructured":"Rawson RA, Simon SL, Ling W: If a US drug abuse epidemic fails to include a major east coast city, can it be called an epidemic? J Addict Dis 2002, 21:1\u20134.","journal-title":"J Addict Dis"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/02791072.2000.10400232","volume":"32","author":"M Maglione","year":"2000","unstructured":"Maglione M, Chao B, Anglin MD: Correlates of outpatient drug treatment drop-out among methamphetamine users. J Psychoactive Drugs 2000, 32:221\u2013228.","journal-title":"J Psychoactive Drugs"},{"key":"16_CR62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15288\/jsa.1999.60.837","volume":"60","author":"RD Stall","year":"1999","unstructured":"Stall RD, Paul JP, Barrett DC, et al.: An outcome evaluation to measure changes in sexual risk-taking among gay men undergoing substance use disorder treatment. J Stud Alcohol 1999, 60:837\u2013845.","journal-title":"J Stud Alcohol"},{"key":"16_CR63","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1360-0443.2004.00707.x","volume":"99","author":"RA Rawson","year":"2004","unstructured":"Rawson RA, Marinelli-Casey P, Anglin MD, et al.: A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004, 99:708\u2013717. Results of an important randomized trial for methamphetamine dependence.","journal-title":"Addiction"},{"key":"16_CR64","unstructured":"Tweaker.org. http:\/\/www.tweaker.org\/. Accessed July 2005."},{"key":"16_CR65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1176\/ajp.150.5.763","volume":"150","author":"ST Higgins","year":"1993","unstructured":"Higgins ST, Budney AJ, Bickel WK, et al.: Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993, 150:763\u2013769.","journal-title":"Am J Psychiatry"},{"key":"16_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0376-8716(88)90030-0","volume":"22","author":"MY Iguchi","year":"1988","unstructured":"Iguchi MY, Stitzer ML, Bigelow GE, et al.: Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend 1988, 22:1\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"16_CR67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2004.10.004","volume":"78","author":"S Shoptaw","year":"2005","unstructured":"Shoptaw S, Reback CJ, Peck JA, et al.: Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005, 78:125\u2013134.","journal-title":"Drug Alcohol Depend"},{"key":"16_CR68","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2001.96912898.x","volume":"96","author":"J Shearer","year":"2001","unstructured":"Shearer J, Wodak A, Mattick RP, et al.: Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction 2001, 96:1289\u20131296.","journal-title":"Addiction"},{"key":"16_CR69","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Rhoades H, Stotts A, et al.: Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004, 29:969\u2013981.","journal-title":"Neuropsychopharmacology"},{"key":"16_CR70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/syn.20097","volume":"55","author":"JD Brodie","year":"2005","unstructured":"Brodie JD, Figueroa E, Laska EM, et al.: Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and\/or cocaine addiction. Synapse 2005, 55:122\u2013125.","journal-title":"Synapse"},{"key":"16_CR71","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1192\/bjp.179.4.356","volume":"179","author":"SF McTavish","year":"2001","unstructured":"McTavish SF, McPherson MH, Harmer CJ, et al.: Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 2001, 179:356\u2013360.","journal-title":"Br J Psychiatry"},{"key":"16_CR72","first-page":"12","volume":"63","author":"SL Batki","year":"2001","unstructured":"Batki SL, Delucchi K, Hersh D, et al.: Amolodipine treatment of methamphetamine dependence, a controlled outpatient trial: preliminary analysis. Drug Alcohol Depend 2001, 63:12.","journal-title":"Drug Alcohol Depend"},{"key":"16_CR73","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.2000.tb06688.x","volume":"909","author":"SL Batki","year":"2000","unstructured":"Batki SL, Moon J, Delucchi K, et al.: Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis. Ann N Y Acad Sci 2000, 909:260\u2013263.","journal-title":"Ann N Y Acad Sci"},{"key":"16_CR74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0740-5472(96)00154-7","volume":"13","author":"GP Galloway","year":"1996","unstructured":"Galloway GP, Newmeyer J, Knapp T, et al.: A controlled trial of imipramine for the treatment of methamphetamine dependence. J Subst Abuse Treat 1996, 13:493\u2013497.","journal-title":"J Subst Abuse Treat"},{"key":"16_CR75","unstructured":"Johnson BA, Rawson R, Elkashef A, et al.: Ondansetron for the treatment of methamphetamine dependence. Paper presented at Sixty-sixth Annual Scientific Meeting of College on Problems of Drug Dependence. San Juan, Puerto Rico; June 12\u201317, 2004."},{"key":"16_CR76","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1360-0443.2005.01032.x","volume":"100","author":"JK Cunningham","year":"2005","unstructured":"Cunningham JK, Liu LM: Impacts of federal precursor chemical regulations on methamphetamine arrests. Addiction 2005, 100:479\u2013488.","journal-title":"Addiction"},{"key":"16_CR77","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1360-0443.2003.00450.x","volume":"98","author":"JK Cunningham","year":"2003","unstructured":"Cunningham JK, Liu LM: Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction 2003, 98:1229\u20131237.","journal-title":"Addiction"},{"key":"16_CR78","first-page":"1","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","unstructured":"Centers for Disease Control and Prevention: Revised guidelines for HIV counseling, testing, and referral. MMWR 2001, 50:1\u201358.","journal-title":"MMWR"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-005-0016-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-005-0016-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-005-0016-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:25:28Z","timestamp":1707902728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-005-0016-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s11904-005-0016-4","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}